Cannabidiol-treated rats exhibited higher motor score after cryogenic spinal cord injury

Neurotoxicity Research

Volumn 21, Issue 3, 2012, Pages 271-280

  Kwiatkoski, Marcelo ^a   Guimarães, Francisco Silveira ^a   Del Bel, Elaine ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

BBB scale; Experimental model; Raquimedular trauma

Indexed keywords

CANNABIDIOL; EOSIN; HEMATOXYLIN; LIQUID NITROGEN; TRANSCRIPTION FACTOR FOSB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASSO BEATTIE AND BRESNAHAN SCALE; COLD INJURY; CONTROLLED STUDY; DISEASE SEVERITY; FUNCTIONAL ASSESSMENT; HISTOPATHOLOGY; LAMINECTOMY; LOCOMOTION; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RATING SCALE; REPRODUCIBILITY; SCORING SYSTEM; SPINAL CORD INJURY; SPINAL CORD VENTRAL HORN; THORACIC SPINE;

ANIMALIA; CANNABIS; RATTUS;

EID: 84861460855     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-011-9273-8     Document Type: Article

References (63)

1. Bamber N, Li H, Lu X, Oudega M, Aebischer P, Xu X (2001) Neurotrophins BDNF and NT-3 promote axonal re-entry into the distal host spinal cord through Schwann cell-seeded minichannels. Eur J Neurosci 13:257-268 (Pubitemid 32142470)
2. Basso M, Beattie S, Bresnahan C (1995) A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12:1-21
3. Basso M, Beattie S, Bresnahan C (1996a) Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 139:244-256
4. Basso M, Beattie S, Bresnahan C, Anderson K, Faden I, Gruner A, Holford R, Hsu Y, Noble J, Nockels L, Perot L, Salzman K, Young W (1996b) MASCIS evaluation of open field locomotor scores: effects of experience and teamwork on reliability. J Neurotrauma 13:343-359 (Pubitemid 26405758)
5. Beattie S, Bresnahan C, Komon J, Tovar A, Van Meter M, Anderson K, Faden I, Hsu Y, Noble J, Salzman S, Young W (1997) Endogenous repair after spinal cord contusion injuries in the rat. Exp Neurol 148:453-463 (Pubitemid 28068841)
6. Braida D, Pegorini S, Arcidiacono V, Consalez G, Croci L, Sala M (2003) Post-ischemic treatment with cannabidiol prevents electroencephalographic flattening, hyperlocomotion and neuronal injury in gerbils. Neurosci Lett 346:61-64 (Pubitemid 36792194)
7. Carlson D, Gorden D, Oliff S, Pillai J, Lamanna C (2003) Sustained spinal cord compression: part I: time-dependent effect on longterm pathophysiology. J Bone Joint Surg Am 85-A:86-94 (Pubitemid 36537978)
8. Carrier J, Auchampach A, Hillard J (2006) Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression. Proc Natl Acad Sci USA 103:7895-7900
9. Castillo A, Tolón M, Fernández-Ruiz J, Romero J, Martinez-Orgado J (2010) The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors. Neurobiol Dis 37:434-440
10. Chen JF, Sonsalla PK, Pedata F, Melani A, Domenici MR, Popoli P, Geiger J, Lopes LV, de Mendonça A (2007) Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and ''fine tuning'' modulation. Prog Neurobiol 83(5):310-331 (Pubitemid 350119825)
11. Cheng H, Cao Y, Olson L (1996) Spinal cord repair in adult paraplegic rats: partial restoration of hind limb function. Science 273:510-513 (Pubitemid 26286454)
12. Collins H, West R, Parmely D, Samson M, Ward A (1986a) The histopathology of freezing injury to the rat spinal cord. A light microscope study. I. Early degenerative changes. J Neurophatol Exp Neurol 45(6):721-741
13. Collins GH, West NR, Parmely JD (1986b) The histopathology of freezing injury to the rat spinal cord. A light and electron microscope study. II. Repair and regeneration. J Neuropathol Exp Neurol 45(6):742-757 (Pubitemid 17181310)
14. Cunha J, Carlini A, Pereira E, Ramos O, Pimentel C, Gagliardi R, Sanvito L, Lander N, Mechoulam R (1980) Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology 21:175-185 (Pubitemid 10039764)
15. Del Bel E, Borges A, Defino L, Guimaraes S (2000) Induction of Fos protein immunoreactivity by spinal cord contusion. Braz J Med Biol Res 33:521-528
16. Drysdale J, Platt B (2003) Cannabinoids: mechanisms and therapeutic applications in the CNS. Curr Med Chem 10:2719-2732 (Pubitemid 37456042)
17. El-Remessy B, Khalil E, Matragoon S, Abou-Mohamed G, Tsai J, Roon P, Caldwell B, Caldwell W, Green K, Liou I (2003) Neuroprotective effect of (-)Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite. Am J Pathol 163:1997-2008 (Pubitemid 37310030)
18. Emery E, Aldana P, Bunge B, Puckett W, Srinivasan A, Keane W, Bethea J, Levi D (1998) Apoptosis after traumatic human spinal cord injury. J Neurosurg 89:911-920 (Pubitemid 28544043)
19. Esposito G, De Filippis D, Carnuccio R, Izzo A, Iuvone T (2006) The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cells. J Mol Med 84:253-258 (Pubitemid 43291014)
20. Feng SQ, Kong XH, Guo SF, Wang P, Li L, Zhong JH, Zhou XF (2005) Treatment of spinal cord injury with co-grafts of genetically modified Schwann cells and fetal spinal cord cell suspension in the rat. Neurotox Res 7(1-2):169-177
21. García-Arencibia M, González S, De Lago E, Ramos A ́ , Mechoulam R, Fernández-Ruiz J (2007) Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties. Brain Res 1134:162-170 (Pubitemid 46135535)
22. Guimarães S, Chiaretti M, Graeff G, Zuard W (1990) Antianxiety effect of cannabidiol in the elevated plus-maze. Psychopharmacology (Berl) 100:558-559
23. Hayakawa K, Mishima K, Nozako M, Ogata A, Hazekawa M, Liu X, Fujioka M, Abe K, Hasebe N, Egashira N, Iwasaki K, Fujiwara M (2007a) Repeated treatment with cannabidiol but not Delta9- tetrahydrocannabinol has a neuroprotective effect without the development of tolerance. Neuropharmacology 52:1079-1087
24. Hayakawa K, Mishima K, Nozako M, Hazekawa M, Irie K, Fujioka M, Orito K, Abe K, Hasebe N, Egashira N, Iwasaki K, FujiwaraMet al (2007b) Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor-independent myeloperoxidase- inhibiting mechanism. J Neurochem 102(5):1488-1496 (Pubitemid 47256190)
25. Houweling A, van Asseldonk J, Lankhorst A, Hamers F, Martin D, Bär R, Joosten A (1998) Local application of collagen containing brain-derived neurotrophic factor decreases the loss of function after spinal cord injury in the adult rat. Neurosci Lett 251: 193-196 (Pubitemid 28381080)
26. Hsu CY, Hogan EL, Gadsden RHS, Spicer KM, Shi MP, Cox RD (1985) Vascular permeability in experimental spinal cord injury. J Neurol Sci 70:275-282 (Pubitemid 15242347)
27. Iannotti CA, Clark M, Horn KP, van Rooijen N, Silver J, Steinmetz MP (2011) A combination immunomodulatory treatment promotes neuroprotection and locomotor recovery after contusion SCI. Exp Neurol 230(1):3-15
28. Iuvone T, Esposito G, Esposito R, Santamaria R, Di Rosa M, Izzo A (2004) Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells. J Neurochem 89:134-141 (Pubitemid 38420682)
29. Izzo A, Borrelli F, Capasso R, Di Marzo V, Mechoulam R (2009) Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci 30:515-527
30. Jonat C, Rahmsdorf HJ, Park KK, Cato AC, Gebel S, Ponta H, Herrlich P (1990) Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62:1189-1204
31. Jones L, Oudega M, Bunge M, Tuszynski M (2001) Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury. J Physiol 533:83-89 (Pubitemid 32499360)
32. Karin M, Liu ZG, Zandi E (1997) AP-1 function and regulation. Curr Opin Cell Biol 9:240-246 (Pubitemid 27135992)
33. Kitada M, Mizoguchi A, Tohyama K, Ohtsubo A, Fujimoto E, Chakrabortty S, Ide C (1999) Comparison of the axonal and glial reactions between the caudal and rostral border in the cryoinjured dorsal funiculus of the rat spinal cord. Restor Neurol Neurosci 14(4):251-263 (Pubitemid 29281704)
34. Lastres-Becker I, Molina-Holgado F, Ramos A, Mechoulam R, Fernández-Ruiz J (2005) Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease. Neurobiol Dis 19:96-107 (Pubitemid 40544727)
35. Leweke M, Schneider U, Radwan M, Schmidt E, Emrich H (2000) Different effects of nabilone and cannabidiol on binocular depth inversion in Man. Pharmacol Biochem Behav 66:175-181 (Pubitemid 30317532)
36. Liu Z, Xu M, Hu R, Du C, Zhang X, Mcdonald W, Dong X,WuJ, Fan S, Jacquin F, Hsu Y, Choi W (1997) Neuronal and glial apoptosis after traumatic spinal cord injury. J Neurosci 17:5395-5406
37. Ma M, Basso M, Walters P, Stokes T, Jakeman B (2001) Behavioral and histological outcomes following graded spinal cord contusion injury in the C57Bl/6 mouse. Exp Neurol 169:239-254 (Pubitemid 32524420)
38. McClung CA, Ulery PG, Perrotti LI, Zachariou V, Berton O, Nestler EJ (2004) DeltaFosB: a molecular switch for long-term adaptation in the brain. Brain Res Mol Brain Res 132(2):146-154 (Pubitemid 39586757)
39. Mechoulam R (2002) Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression. Prostaglandins Leukot Essent Fatty Acids 66:93-99 (Pubitemid 34743588)
40. Menei P, Montero-Menei C, Whittemore S, Bunge R, Bunge M (1998) Schwann cells genetically modified to secrete human BDNF promote enhanced axonal regrowth across transected adult rat spinal cord. Eur J Neurosci 10:607-621 (Pubitemid 28325484)
41. Mishima K, Hayakawa K, Abe K, Ikeda T, Egashira N, Iwasaki K, Fujiwara M (2005) Cannabidiol prevents cerebral infarction via a serotonergic 5-Hydroxytryptamine 1A receptor-dependent mechanism. Stroke 36:1071-1076 (Pubitemid 40629305)
42. Molander C, Xu Q, Rivero-Melian C, Grant G (1989) Cytoarchitectonic organization of the spinal cord in the rat: II. The cervical and upper thoracic cord. J Comp Neurol 289:375-385 (Pubitemid 19277915)
43. Nestler EJ (2008) Transcriptional mechanisms of addiction: role of DeltaFosB. Philos Trans R Soc Lond B Biol Sci 363(1507): 3245-3255
44. Pertwee G (2001) Cannabinoids receptors and pain. Prog Neurobiol 63:569-611
45. Pertwee G (2005) Inverse agonism and neutral antagonism at cannabinoid CB1 receptors. Life Sci 12:1307-1324
46. Plemel R, Duncan G, Chen W, Shannon C, Park S, Sparling S, Tetzlaff W (2008) A graded forceps crush spinal cord injury model in mice. J Neurotrauma 25:350-370 (Pubitemid 351457763)
47. Ruggiero A, Anwar M, Kim J, Sica L, Gootman N, Gootman M (1997) Induction of c-fos gene expression by spinal cord transection in the rat. Brain Res 763:21-29 (Pubitemid 27323734)
48. + levels. J Neurosci 29:2053-2063
49. Scuderi C, Filippis D, Iuvone T, Blasio A, Steardo A, Esposito G (2009) Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders. Phytother Res 23:597-602
50. Sharma S, Westman J, Olsson Y, Alm P (1996) Involvement of nitric oxide in acute spinal cord injury: an immunocytochemical study using light and electron microscopy in the rat. Neurosci Res 24:373-384 (Pubitemid 26114183)
51. Tator CH (1995) Update on the pathophysiology and pathology of acute spinal cord injury. Brain Pathol 5(4):407-413
52. Tator CH (1996) Experimental and clinical studies of the pathophysiology and management of acute spinal cord injury. J Spinal Cord Med 19(4):206-214 (Pubitemid 126768336)
53. Tator CH (1998) Biology of neurological recovery and functional restoration after spinal cord injury. Neurosurgery 42(4):696-707
54. Thomas A, Baillie L, Phillips M, Razdan K, Ross A, Pertwee G (2007) Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro. Br J Pharmacol 150:613-623 (Pubitemid 46355558)
55. Wada S, Yone K, Ishidou Y, Nagamine T, Nakahara S, Niiyama T, Sakou T (1999) Apoptosis following spinal cord injury in rats and preventative effect of N-methyl-D-aspartate receptor antagonist. J Neurosurg 91:S98-S104
56. Watson C, Paxinos G, Kayalioglu G (2009) The spinal cord. A Christopher and Dana Reeve Foundantion text and atlas. Academic Press, San Diego
57. Webb A, Ngan S, Fowler D (2010) Spinal cord injury I: a synopsis of the basic science. Can Vet J 51:485-492
58. Wisdom R (1999) AP-1: one switch for many signals. Exp Cell Res 253:180-185
59. Xu M, Guénard V, Kleitman N, Aebischer P, Bunge B (1995) A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord. Exp Neurol 134:261-272
60. Xu J, Kim M, Ahmed H, Xu J, Yan P, Xu M, Hsu Y (2001) Glucocorticoid receptor-mediated suppression of activator protein- 1 activation and matrix metalloproteinase expression after spinal cord injury. J Neurosci 1:92-97 (Pubitemid 32098730)
61. Yang K, Mu S, Xue J, Whitson J, Salminen A, Dixon E, Liu K, Hayes L (1994) Increased expression of c-fos mRNA and AP-1 transcription factors after cortical impact injury in rats. Brain Res 664:141-147 (Pubitemid 2161794)
62. Zhang ZF, Liao WH, Yang QF, Li HY, Wu YM, Zhou XF (2003) Protective effects of adenoviral cardiotrophin-1 gene transfer on rubrospinal neurons after spinal cord injury in adult rats. Neurotox Res 5:539-548
63. Zuardi A, Crippa J, Hallak J, Moreira F, Guimarães FS (2006) Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. Braz J Med Biol Res 39:421-429